key: cord-0841011-20lspwwc authors: Mohapatra, Ranjan K.; Tiwari, Ruchi; Sarangi, Ashish K.; Sharma, Sanjay K.; Khandia, Rekha; Saikumar, G.; Dhama, Kuldeep title: Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinent date: 2022-02-12 journal: J Med Virol DOI: 10.1002/jmv.27585 sha: 72b284791193f05a2de6bf9d0efd5e66f24e67e6 doc_id: 841011 cord_uid: 20lspwwc The emergence of Omicron (B.1.1.529) variant of SARS‐CoV‐2 has resulted into a very massive surge in COVID‐19 cases worldwide. Due to continuous emergence of multiple variants of SARS‐CoV‐2, the ongoing pandemic has caused severe morbidity and mortality in last two years. The rate of infectivity of Omicron variant is much higher than Delta variant and in a very quick time Omicron has displaced the Delta variant and now become a dominant variant across the globe. The twin combination of Omicron and Delta variant is triggering a Tsunami wave of ever high surges in COVID‐19 cases worldwide. This article highlights the global threats and challenges posed by Omicron, and strategies to counter it with a particular focus on Indian sub‐continent. be seen as soon as it is introduced and established itself in the population of a country. 11 Omicron has been found to be partially resistant to COVID-19 vaccine-induced immunity and overpowering key antibody-based immunotherapies. [12] [13] [14] As the mutations help the virus to partially evade the immune responses, the present COVID- 19 vaccines are less effective to prevent infection with Omicron; thus, a large number of breakthrough infections are being reported in vaccinated individuals worldwide. 15, 16 The Pfizer-BioNTech has suggested a booster dose after two existing vaccine doses, which may potentially provide protection of up to 25% against the Omicron variant. Moderna also pointed to a third vaccine dose, which may increase protective antibody levels of the body to fight against infection with Omicron. The Omicron variant is observed to replicate more than 70 times in human bronchus, but less efficiently in the lung tissue as compared to the Delta variant. 17 As per the report, the Omicron RBD binds to human angiotensin-converting enzyme 2 receptors with enhanced affinity. 18 The lower replication ability in human lung suggests less disease severity of Omicron as compared to the Delta variant. The immunity induced from the COVID-19 vaccines, booster doses, and previous SARS-CoV-2 infections may be the possible reasons for lower hospitalization and mortality in Omicron cases, and lastly, the newer variant being of mild nature as compared to other variants such as Delta. 19, 20 The previous variants (Alpha, Beta, and Delta) have caused consecutive waves of COVID-19 across the entire world, 4,21,22 so the researchers are now speculating a new wave of the ongoing pandemic due to the Omicron variant owing to its very high transmissibility with the doubling time to be 1.5 to 3 days. [23] [24] [25] The world has witnessed the devastating effects of the third wave of COVID-19 pandemic a few months back, wherein particularly the delta variant lead to a high surge in cases owing to its high transmission rates, ability to cause severe disease, reinfection, causing severe breakthrough infections in vaccinated individuals, and especially affecting nonvaccinated and vulnerable persons severely, altogether adding to the massive rise in the number of deaths worldwide. 22, [26] [27] [28] As per the studies, Omicron cases may not be posing severe illness, especially for vaccinated people and those who have received a booster shot. [29] [30] [31] Although, until now, the Omicron variant is considered as milder as compared to previous SARS-CoV-2 VoCs such as Delta, however, much is yet to be known about this newly emerged variant; infected individuals can transmit it potentially to the vulnerable population and to those who are immunocompromised, elderly, suffering from comorbid diseases, and coinfections, and even if such persons may be vaccinated, omicron infection might result into complicated illness or deaths as has been observed earlier with infection from SARS-CoV-2 and its variants in such highly susceptible population. [32] [33] [34] It should also be kept in mind that despite the current assumption on Omicron causing low-to-mild disease severity with lesser requirements of hospital admittance, the chances of acquiring Omicron infection in the household and community settings are much higher than that of the Delta variant due to its very high transmission rates, and the scenario of the vulnerable population getting infected more and more may lead to alarming health concerns worldwide as the number of cumulative deaths will increase globally. 11, 20 Omicron and Delta variants, both possessing higher transmissibility, posing threats on the efficacy of vaccines and causing breakthrough infections in vaccinated individuals, may together bring a tsunami of COVID-19 cases in the coming weeks, and then hospitalizations and death rates might also rise significantly. 22, 27 Omicron was first identified in India on November 25 and is now detected in most of the states in a very quick time and may soon dominate over the Delta variant. 5 As on January 5, 2022, India reported nearly 2200 Omicron cases, and most importantly, Omicroninfected persons are already vaccinated. So, we are afraid that whether two doses of COVD-19 vaccines is enough to counter this new variant. 29 In this context, several countries such as the United week as of January 5, 2022. 8, 9 Genomic sequencing is being performed on only a small number of COVID-19 cases, hence the actual number of Omicron cases might be significantly higher, and this variant is spreading more and more continuously into the population. 8 India's tally of COVID-19 cases has very recently seen a rise of nearly eight times, from around 7000 to over 58,000 cases in the past few days as of January 5, 2022 with a rapid surge in Omicron cases (https://www.mygov.in/covid-19/, accessed on January 5, 2022). 9 The United States, Canada, and the European countries 36 The Omicron variant is now potentially circulating throughout the country and may be responsible for another fresh wave (the so-called third wave) in the coming weeks. Moreover, the current vaccines are reported to be less effective but still provide some protection against Omicron, and adding up of booster doses will increase the protection level to avoid breakthrough infections and disease severity. A massive awareness programme for the general public for convincing them to take up a full course of vaccination along with booster dose as well as strict implementation of adequate COVID-19 safety measures, prevention, and control strategies should be the immediate priority before the Omicron causes a very high surge in cases. 37 Vaccination is not only the ultimate way, and as per the given global data, India is yet to vaccinate half of its population to achieve as fully vaccinated people (https://www. proactive and targeted control measures to counter this newer variant having the substantial advantage of speedy transmission, and also the Delta variant needs to be given the top priority at the global level amid the ongoing pandemic. 11, 26, 33, [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] ACKNOWLEDGMENTS All the authors acknowledge and thank their respective institutes and universities of affiliation. Coronavirus disease 2019-COVID-19 The recent challenges of highly contagious COVID-19; causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models and immunotherapy COVID-19) Dashboard. WHO COVID-19 Dashboard-Up to date data on pandemic Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern OMICRON VARIANT (B.1.1.529). Data from BNO News/Newsnodes Worldmeter COVID-19 coronavirus pandemic Winter of Omicron-the evolving COVID-19 pandemic Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark Omicron overpowers key COVID antibody treatments in early tests SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance Omicron likely to weaken COVID vaccine protection Omicron puts scientists on red alert SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor Covid-19: early studies give hope omicron is milder than other variants Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern Novel SARS-CoV-2 variants: the pandemics within the pandemic Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic SARS-CoV-2 variants and ending the COVID-19 pandemic Department of Health, Government of South Africa Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic The challenges of COVID-19 Delta variant: prevention and vaccine development SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era Omicron variant and booster COVID-19 vaccines mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. medRxiv Covid 19: US cases rise amid omicron fears but booster shots offer protection, experts say COVID-19 and the world with co-morbidities of heart disease, hypertension and diabetes Covid-19-vaccins in het deltatijdperk Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets-magnifying global pandemic grieve and catastrophe begins Consecutive hits of COVID-19 in India: the mystery of plummeting cases and current scenario COVID-19, WHO guidelines, pedagogy, and respite Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear Deltacron: the story of the variant that wasn't Contact tracing as a measure to combat COVID-19 and other infectious diseases highlights Omicron: a drug developer's perspective Preparing for Omicron as a Covid veteran Stopping coronavirus variants Omicron: a failure to act with a global focus will continue the proliferation of new variants of Covid-19 Characteristics and control measures of 2019 novel coronavirus Delta variant of concern How to translate the knowledge of COVID-19 into the prevention of Omicron variants 19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination Omicron SARS-CoV-2 variant: unique features and their impact on pre-existing antibodies The global epidemic of the SARS-CoV-2 Delta variant, key spike mutations and immune escape Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent The authors declare that there are no conflict of interests. All the authors contributed significantly to this manuscript. Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.